Authors:
Daniel, L
Durbec, P
Gautherot, E
Rouvier, E
Rougon, G
Figarella-Branger, D
Citation: L. Daniel et al., A nude mice model of human rhabdomyosarcoma lung metastases for evaluatingthe role of polysialic acids in the metastatic process, ONCOGENE, 20(8), 2001, pp. 997-1004
Authors:
de Labriolle-Vaylet, C
Cattan, P
Sarfati, E
Wioland, M
Billotey, C
Brocheriou, C
Rouvier, E
de Roquancourt, A
Rostene, W
Askienazy, S
Barbet, J
Milhaud, G
Gruaz-Guyon, A
Citation: C. De Labriolle-vaylet et al., Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery, CLIN CANC R, 6(2), 2000, pp. 363-371
Authors:
Gautherot, E
Rouvier, E
Daniel, L
Loucif, E
Bouhou, J
Manetti, C
Martin, M
Le Doussal, JM
Barbet, J
Citation: E. Gautherot et al., Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and I-131-labeled bivalent hapten, J NUCL MED, 41(3), 2000, pp. 480-487
Authors:
Gautherot, E
Kraeber-Bodere, F
Daniel, L
Fiche, M
Rouvier, E
Sai-Maurel, C
Thedrez, P
Chatal, JF
Barbet, J
Citation: E. Gautherot et al., Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with I-131-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody, CLIN CANC R, 5(10), 1999, pp. 3177S-3182S
Authors:
Kraeber-Bodere, F
Bardet, S
Hoefnagel, CA
Vieira, MR
Vuillez, JP
Murat, A
Ferreira, TC
Bardies, M
Ferrer, L
Resche, I
Gautherot, E
Rouvier, E
Barbet, J
Chatal, JF
Citation: F. Kraeber-bodere et al., Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: Preliminary results of a phase I/II clinical trial, CLIN CANC R, 5(10), 1999, pp. 3190S-3198S
Authors:
Vuillez, JP
Kraeber-Bodere, F
Moro, D
Bardies, M
Douillard, JY
Gautherot, E
Rouvier, E
Barbet, J
Garban, F
Moreau, P
Chatal, JF
Citation: Jp. Vuillez et al., Radioimmunotherapy of small cell lung carcinoma with the two-step method using a bispecific anti-carcinoembryonic antigen/anti-diethylenetriaminepentaacetic acid (DTPA) antibody and iodine-131 Di-DTPA hapten: Results of a phase I/II trial, CLIN CANC R, 5(10), 1999, pp. 3259S-3267S